Immunohistology: An Overview

Miaomiao Liu^*
*Correspondence: Miaomiao Liu, Department of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China, Email:

Editorial

The diagnosis of the various variants of MIDD relies heavily on immunohistochemistry. Monotypic light-chain or heavy-chain fixation along tubular basement membranes is a necessary requirement for the diagnosis of MIDD. Tubular deposits stain brightly and are most commonly found along the Henle loops and distal tubules, but they can also be found in the proximal tubules. Glomerular immunohistochemistry patterns, on the other hand, are highly variable. Monotypic immunoglobulin chains are identified in the peripheral GBM and, to a lesser extent, in the nodules themselves in patients with nodular glomerulosclerosis. Glomerular staining is usually weaker than the staining seen along tubular basement membranes. Because glomerular immunohistology may be negative despite significant granular glomerular deposits, this may not reflect the real amount of deposited material.

The most prevalent application of immunostaining is Immunohistochemistry (IHC). It entails using the idea of antibodies attaching particularly to antigens in biological tissues to selectively identify antigens (proteins) in cells of a tissue segment. IHC is derived from the words "immuno," which refers to the antibodies employed in the technique, and "histo," which means "tissue" (compare to immunocytochemistry). In 1941, Albert Coons devised and implemented the process for the first time.

As a result, local alterations to deposited light chains may alter their antigenicity. Glomerular staining occurs along the basement membrane and less commonly in the mesangium in patients without nodular lesions. Bowman's capsule is generally stained in a linear pattern. In the vascular walls and interstitium, deposits are common. The premise of immunohistology is based on an antigen being recognised by a specific antibody, and the antigenantibody complex being revealed either through a chemical reaction (IHC immunohistochemistry) utilising an enzyme and its substrate, or through the use of a fluorescent secondary antibody (IF immunofluorescence). On the same tissue segment, a single protein (single labelling) or numerous proteins can be found (multiple labeling).

Immunopathology is a discipline of medicine that studies disease-related immunological responses. It entails the investigation of an organism's, organ systems, or disease's pathology in relation to the immune system, immunity, and immunological responses. It is a term used in biology to describe the harm caused by an organism's own immune response as a result of an infection. It could be due to a pathogen-host species mismatch, which happens frequently when an animal pathogen infects a human (e.g. avian flu leads to a cytokine storm which contributes to the increased mortality rate).

Despite characteristic nodular glomerulosclerosis, immunohistology with anti–light-chain antibodies is negative in patients with HCDD. It's possible to find monotypic deposits of, or hefty chains. It is possible to observe any subclass. In all of the cases investigated, monoclonal antibodies specific for the constant domains of the heavy chain were used to identify a deletion of the CH1 domain in the kidney biopsy specimen. In most situations of HCDD, complement components such as C1 could be seen in a granular or pseudo linear form, especially when a 1 or 3 chain is involved. Complement deposits were frequently linked to serum markers of complement activation [1-5].

Conflict of Interest

None.

References

1. Ajura, A. J., I. Sumairi, and S. H. Lau. "The use of immunohistochemistry in an oral pathology laboratory." J Pathol 29 (2007):101–105.

Google Scholar, Indexed at

2. Edgar, Mark A., and Marc K. Rosenblum. "The differential diagnosis of central nervous system tumors: a critical examination of some recent immunohistochemical applications." Arch Pathol Lab Med 132 (2008): 500–509. 

Google Scholar, Crossref, Indexed at

3. Garcia, Christine F., and Steven H. Swerdlow. "Best practices in contemporary diagnostic immunohistochemistry: panel approach to hematolymphoid proliferations." Arch Pathol Lab Med 133 (2009): 756–765. 

Google Scholar, Crossref, Indexed at

4. Leong, AS‐Y., and J. Wright. "The contribution of immunohistochemical staining in tumour diagnosis." Histopathology 11(1987): 1295–1305. 

Google Scholar, Crossref, Indexed at

5. Bernardi, F. D. C., P. H. N. Saldiva, and T. Mauad. "Histological examination has a major impact on macroscopic necropsy diagnoses." J Clin Pathol 58 (2005): 1261–1264. 

Google Scholar, Crossref, Indexed at